George Scangos' Bold Vision Post author:Sam Post published:October 24, 2017 Post category:BioPharma The former Biogen CEO is making waves at his new venture, Vir Biotechnology. Source: BioSpace You Might Also Like <b>Revon Systems</b> Working With To Build Next Generation Clinical Algorithms September 6, 2017 Bay Area's CytomX Surges as Bristol-Myers Squibb Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion March 19, 2017 The World's Richest Doctor Loses Top NantHealth Exec May 7, 2017
Bay Area's CytomX Surges as Bristol-Myers Squibb Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion March 19, 2017
